250 related articles for article (PubMed ID: 24951107)
1. Complexities of androgen receptor signalling in breast cancer.
McNamara KM; Moore NL; Hickey TE; Sasano H; Tilley WD
Endocr Relat Cancer; 2014 Aug; 21(4):T161-81. PubMed ID: 24951107
[TBL] [Abstract][Full Text] [Related]
2. Secreted indicators of androgen receptor activity in breast cancer pre-clinical models.
Hanamura T; Christenson JL; O'Neill KI; Rosas E; Spoelstra NS; Williams MM; Richer JK
Breast Cancer Res; 2021 Nov; 23(1):102. PubMed ID: 34736512
[TBL] [Abstract][Full Text] [Related]
3. Bringing androgens up a NOTCH in breast cancer.
Tarulli GA; Butler LM; Tilley WD; Hickey TE
Endocr Relat Cancer; 2014 Aug; 21(4):T183-202. PubMed ID: 25001242
[TBL] [Abstract][Full Text] [Related]
4. Effects of cytokines derived from cancer-associated fibroblasts on androgen synthetic enzymes in estrogen receptor-negative breast carcinoma.
Kikuchi K; McNamara KM; Miki Y; Moon JY; Choi MH; Omata F; Sakurai M; Onodera Y; Rai Y; Ohi Y; Sagara Y; Miyashita M; Ishida T; Ohuchi N; Sasano H
Breast Cancer Res Treat; 2017 Dec; 166(3):709-723. PubMed ID: 28831645
[TBL] [Abstract][Full Text] [Related]
5. Androgen receptor and FOXA1 coexpression define a "luminal-AR" subtype of feline mammary carcinomas, spontaneous models of breast cancer.
Dagher E; Royer V; Buchet P; Abadie J; Loussouarn D; Campone M; Nguyen F
BMC Cancer; 2019 Dec; 19(1):1267. PubMed ID: 31888566
[TBL] [Abstract][Full Text] [Related]
6. The Role of the Androgen Receptor Signaling in Breast Malignancies.
Christopoulos PF; Vlachogiannis NI; Vogkou CT; Koutsilieris M
Anticancer Res; 2017 Dec; 37(12):6533-6540. PubMed ID: 29187427
[TBL] [Abstract][Full Text] [Related]
7. AIB1 sequestration by androgen receptor inhibits estrogen-dependent cyclin D1 expression in breast cancer cells.
De Amicis F; Chiodo C; Morelli C; Casaburi I; Marsico S; Bruno R; Sisci D; Andò S; Lanzino M
BMC Cancer; 2019 Nov; 19(1):1038. PubMed ID: 31684907
[TBL] [Abstract][Full Text] [Related]
8. Editorial: The Androgen Receptor in Breast Cancer.
Tesei A; Castoria G
Front Endocrinol (Lausanne); 2020; 11():636480. PubMed ID: 33519718
[No Abstract] [Full Text] [Related]
9. Minireview: The androgen receptor in breast tissues: growth inhibitor, tumor suppressor, oncogene?
Hickey TE; Robinson JL; Carroll JS; Tilley WD
Mol Endocrinol; 2012 Aug; 26(8):1252-67. PubMed ID: 22745190
[TBL] [Abstract][Full Text] [Related]
10. Androgen receptor expression in breast cancer: Implications on prognosis and treatment, a brief review.
Jahan N; Jones C; Rahman RL
Mol Cell Endocrinol; 2021 Jul; 531():111324. PubMed ID: 34000352
[TBL] [Abstract][Full Text] [Related]
11. Role of the androgen receptor in triple-negative breast cancer.
Rampurwala M; Wisinski KB; O'Regan R
Clin Adv Hematol Oncol; 2016 Mar; 14(3):186-93. PubMed ID: 27058032
[TBL] [Abstract][Full Text] [Related]
12. Androgen receptor signaling pathways as a target for breast cancer treatment.
Pietri E; Conteduca V; Andreis D; Massa I; Melegari E; Sarti S; Cecconetto L; Schirone A; Bravaccini S; Serra P; Fedeli A; Maltoni R; Amadori D; De Giorgi U; Rocca A
Endocr Relat Cancer; 2016 Oct; 23(10):R485-98. PubMed ID: 27528625
[TBL] [Abstract][Full Text] [Related]
13. Anti-proliferative transcriptional effects of medroxyprogesterone acetate in estrogen receptor positive breast cancer cells are predominantly mediated by the progesterone receptor.
Moore NL; Hanson AR; Ebrahimie E; Hickey TE; Tilley WD
J Steroid Biochem Mol Biol; 2020 May; 199():105548. PubMed ID: 31805393
[TBL] [Abstract][Full Text] [Related]
14. Selective Androgen Receptor Modulator RAD140 Inhibits the Growth of Androgen/Estrogen Receptor-Positive Breast Cancer Models with a Distinct Mechanism of Action.
Yu Z; He S; Wang D; Patel HK; Miller CP; Brown JL; Hattersley G; Saeh JC
Clin Cancer Res; 2017 Dec; 23(24):7608-7620. PubMed ID: 28974548
[No Abstract] [Full Text] [Related]
15. Androgen Receptor Biology in Triple Negative Breast Cancer: a Case for Classification as AR+ or Quadruple Negative Disease.
Barton VN; D'Amato NC; Gordon MA; Christenson JL; Elias A; Richer JK
Horm Cancer; 2015 Dec; 6(5-6):206-13. PubMed ID: 26201402
[TBL] [Abstract][Full Text] [Related]
16. Androgen-induced human breast cancer cell proliferation is mediated by discrete mechanisms in estrogen receptor-alpha-positive and -negative breast cancer cells.
Lin HY; Sun M; Lin C; Tang HY; London D; Shih A; Davis FB; Davis PJ
J Steroid Biochem Mol Biol; 2009 Feb; 113(3-5):182-8. PubMed ID: 19159686
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the roles of estrogens and androgens in breast cancer and prostate cancer.
Liu WJ; Zhao G; Zhang CY; Yang CQ; Zeng XB; Li J; Zhu K; Zhao SQ; Lu HM; Yin DC; Lin SX
J Cell Biochem; 2020 Apr; 121(4):2756-2769. PubMed ID: 31693255
[TBL] [Abstract][Full Text] [Related]
18. Cholesterol synthesis inhibitor RO 48-8071 suppresses transcriptional activity of human estrogen and androgen receptor.
Mafuvadze B; Liang Y; Hyder SM
Oncol Rep; 2014 Oct; 32(4):1727-33. PubMed ID: 25051231
[TBL] [Abstract][Full Text] [Related]
19. Androgen receptor expression predicts beneficial tamoxifen response in oestrogen receptor-α-negative breast cancer.
Hilborn E; Gacic J; Fornander T; Nordenskjöld B; Stål O; Jansson A
Br J Cancer; 2016 Feb; 114(3):248-55. PubMed ID: 26742006
[TBL] [Abstract][Full Text] [Related]
20. Androgens induce divergent proliferative responses in human breast cancer cell lines.
Birrell SN; Bentel JM; Hickey TE; Ricciardelli C; Weger MA; Horsfall DJ; Tilley WD
J Steroid Biochem Mol Biol; 1995 May; 52(5):459-67. PubMed ID: 7748811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]